Amin Naseem
Insider CIK 1646754 · AVDL Director · BLPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 49,500 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 11,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 11,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer | 2026-02-12 | 2026-02-12 | 22,000 | $21.00 | $462.0K | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2025-07-29 | 2025-07-31 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award | 2025-07-29 | 2025-07-31 | 11,000 | — | $0 | 22,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2024-07-30 | 2024-08-01 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award | 2024-07-30 | 2024-08-01 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2024-05-17 | 2024-05-21 | 49,500 | — | $0 | 49,500 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2023-06-07 | 2023-06-09 | 47,578 | — | $0 | 291,865 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2023-02-10 | 2023-02-14 | 84,000 | — | $0 | 244,287 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2021-12-31 | 2022-01-04 | 8,671 | $3.10 | $26.9K | 23,809 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2021-12-31 | 2022-01-04 | 39,032 | — | $0 | 160,287 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2020-09-10 | 2020-09-14 | 6,509 | $10.12 | $65.9K | 15,138 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2019-09-26 | 2019-09-30 | 46,266 | — | $0 | 109,482 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2019-01-25 | 2019-01-25 | 571,429 | $0.70 | $400.0K | 1,818,867 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2018-06-21 | 2018-06-25 | 17,124 | — | $0 | 1,247,438 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2018-06-05 | 2018-06-07 | 38,216 | $2.27 | $86.8K | 83,216 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy deriv | 2017-09-29 | 2017-10-03 | 456,432 | — | $0 | 456,432 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2017-09-29 | 2017-10-03 | 456,432 | — | $0 | 1,230,314 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2017-09-22 | 2017-09-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2017-06-28 | 2017-07-03 | 36,232 | — | $0 | 773,882 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy deriv | 2016-11-29 | 2016-12-01 | 714,285 | — | $0 | 714,285 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2016-11-29 | 2016-12-01 | 714,285 | — | $0 | 737,650 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2016-06-17 | 2016-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2016-04-28 | 2016-04-29 | 23,365 | — | $0 | 23,365 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2015-06-29 | 2015-07-01 | 25,000 | — | $0 | 25,000 | SEC↗ |